IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10.
Saved in:
| Title: | IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10. |
|---|---|
| Authors: | Fonseca MM; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Davoli-Ferreira M; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.; Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Santa-Cecília F; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Guimarães RM; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.; Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Oliveira FFB; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Kusuda R; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Ferreira DW; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Alves-Filho JC; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Cunha FQ; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil., Cunha TM; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil. |
| Source: | Frontiers in immunology [Front Immunol] 2020 Jan 28; Vol. 10, pp. 3059. Date of Electronic Publication: 2020 Jan 28 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32047492 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fonseca+MM%22">Fonseca MM</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Davoli-Ferreira+M%22">Davoli-Ferreira M</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.; Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Santa-Cecília+F%22">Santa-Cecília F</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Guimarães+RM%22">Guimarães RM</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.; Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Oliveira+FFB%22">Oliveira FFB</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Kusuda+R%22">Kusuda R</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Ferreira+DW%22">Ferreira DW</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Alves-Filho+JC%22">Alves-Filho JC</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Cunha+FQ%22">Cunha FQ</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Cunha+TM%22">Cunha TM</searchLink>; Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 Jan 28; Vol. 10, pp. 3059. <i>Date of Electronic Publication: </i>2020 Jan 28 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32047492 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2019.03059 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3059 Titles: – TitleFull: IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fonseca MM – PersonEntity: Name: NameFull: Davoli-Ferreira M – PersonEntity: Name: NameFull: Santa-Cecília F – PersonEntity: Name: NameFull: Guimarães RM – PersonEntity: Name: NameFull: Oliveira FFB – PersonEntity: Name: NameFull: Kusuda R – PersonEntity: Name: NameFull: Ferreira DW – PersonEntity: Name: NameFull: Alves-Filho JC – PersonEntity: Name: NameFull: Cunha FQ – PersonEntity: Name: NameFull: Cunha TM IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 01 Text: 2020 Jan 28 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |